MYASTERIX

Clinical safety, immunogenicity and efficacy of a therapeutic vaccine that combines peptides mimicking antigen receptors on autoimmune B and T cells associated with myasthenia gravis

CoordinatorACADEMISCH ZIEKENHUIS LEIDEN ; AEPODIA SA ; PICHEM FORSCHUNGS-UND ENTWICKLUNGSGMBH ; CURAVAC EUROPE SPRL ; INSERM TRANSFERT SA
Grant period2013-10-01 - 2018-09-30
Funding bodyEuropean Union
Call numberFP7-HEALTH-2013-INNOVATION-1
Grant number602420
IdentifierG:(EU-Grant)602420

     

Recent Publications

There are no publications


 Record created 2014-10-20, last modified 2023-02-28



Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)